Want to join the conversation?
$MMC said that its 2015 underlying revenue growth was 5%. The company's 8% adjusted EPS growth was driven by higher operating income with margin expansion in both the RIS and Consulting segments, while absorbing $0.18 of negative FX impact. Consolidated margin rose 100 BP to 19.1%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.